Roberta Lipson, Chindex CEO, commented from Beijing, ''We are thrilled tohave finally received the authorizations we have been waiting for. We havebeen in preparatory discussions for many months with potential hospitalcustomers in China related to the exciting daVinci S product. We will nowbegin immediately to move ahead with the sales process for the prospects inour pipeline. In many cases, our customers will be required to go through aformal budgeting approval or tendering process as part of their procurementprocedures. These steps could not be accomplished before the SFDA approval wasin hand. We were also pleased to receive regulatory approval for theAlexLaser, the Q-switched Alexandrite laser that is used for tattoo andpigmentation removal. There is a substantial market in China for theselasers, and we are now finally able to offer a product to satisfy it. Both ofthese regulatory approvals were long awaited and faced the significant delaysthat are unfortunately very common in the medical device approval process inChina today. We now look forward to the benefit that we will see from theaddition of these key products to our portfolio.''

Chindex is the exclusive distributor of the daVinci S Surgical System inmainland China and Hong Kong and maintains a nationwide sales and technicalservice team to support daVinci system sales in all major metropolitan areasin mainland China and Hong Kong. The revolutionary robotic technology fromIntuitive Surgical is designed to extend the benefits of minimally invasivesurgery to a broad base of patients. Since its development and introduction in1999 there have been more than 850 daVinci systems installed worldwide.Chindex has placed four systems in Hong Kong since introducing the system inthat market in 2005. The systems are all used in various departments forurology, gynecology, general surgery, pediatric, thoracic and ENT cases. Aninitial reference and testing site at the People's Liberation Army GeneralHospital in Beijing has been in service since January 2007. Nearly 100robotic cardiac cases have been performed successfully since that time.

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcareservices and supplies medical capital equipment, instrumentation and productsto the Chinese marketplace, including Hong Kong. It provides healthcareservices through the operations of its United Family Hospitals and Clinics, anetwork of private primary care hospitals and affiliated ambulatory clinics inChina. The Company's hospital network currently operates in the Beijing andShanghai metropolitan areas. The Company sells medical products manufacturedby various major multinational companies, including Siemens AG and IntuitiveSurgical, which are the Company's exclusive distribution partners for the saleand servicing of color doppler ultrasound systems and surgical robotic systemsrespectively. It also arranges financing packages for the supply of medicalproducts to hospitals in China utilizing the export loan and loan guaranteeprograms of both the U.S. Export-Import Bank and the German KfW DevelopmentBank. With twenty-seven years of experience, more than 1,300 employees, andoperations in China, Hong Kong, the United States and Germany, the Company'sstrategy is to expand its cross-cultural reach by providing leading edgehealthcare technologies, quality products and services to Greater China'sprofessional communities. Further company information may be found at theCompany's websites, http://www.chindex.com andhttp://www.unitedfamilyhospitals.com .

For more information, please contact: Judy Zakreski Lawrence Pemble Tel: +1-301-215-7777SOURCE Chindex International, Inc.